HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingying Le Selected Research

Formyl Peptide Receptors (Formyl Peptide Receptor)

10/2020The G-protein-coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy.
1/2019Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization.
1/2005Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.
10/2004Silencing the formylpeptide receptor FPR by short-interfering RNA.
7/2004TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways.
11/2003IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases.
11/2002Formyl-peptide receptors revisited.
10/2002Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.
1/2002Receptors for chemotactic formyl peptides as pharmacological targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingying Le Research Topics

Disease

19Inflammation (Inflammations)
01/2020 - 01/2002
12Alzheimer Disease (Alzheimer's Disease)
04/2013 - 01/2002
8Neoplasms (Cancer)
01/2021 - 01/2002
6Infections
01/2020 - 01/2002
6Insulin Resistance
01/2019 - 12/2010
4Obesity
11/2021 - 01/2011
3Wounds and Injuries (Trauma)
10/2021 - 01/2014
3Carcinogenesis
01/2020 - 09/2011
3Muscle Cramp (Cramp)
01/2020 - 06/2013
3Type 2 Diabetes Mellitus (MODY)
11/2016 - 01/2010
3Glioblastoma (Glioblastoma Multiforme)
08/2008 - 06/2005
2Hyperglycemia
11/2021 - 11/2016
2Hyperlipidemias (Hyperlipidemia)
11/2021 - 12/2010
2Neoplasm Metastasis (Metastasis)
01/2013 - 08/2008
2Neuroinflammatory Diseases
10/2011 - 01/2010
2Amyloid Plaque
09/2010 - 12/2009
2Leukemia
02/2010 - 10/2004
2Immune System Diseases (Immune Disorders)
04/2007 - 01/2002
2Glioma (Gliomas)
06/2005 - 10/2004
1Hypercholesterolemia
11/2021
1Hypertriglyceridemia
11/2021
1Ischemia
10/2021
1Necrosis
10/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
10/2020
1Liver Neoplasms (Liver Cancer)
02/2016
1Hepatocellular Carcinoma (Hepatoma)
02/2016
1Colonic Neoplasms (Colon Cancer)
01/2013
1Diabetic Nephropathies (Diabetic Nephropathy)
04/2012
1Stroke (Strokes)
10/2011
1Brain Ischemia (Cerebral Ischemia)
10/2011
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2011
1Hemorrhage
10/2011
1Autoimmune Diseases (Autoimmune Disease)
10/2011
1Overweight
01/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2011
1Hypoglycemia (Reactive Hypoglycemia)
12/2010
1Dementia (Dementias)
09/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2010
1Astrocytoma (Pilocytic Astrocytoma)
08/2008

Drug/Important Bio-Agent (IBA)

9Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
10/2020 - 01/2002
9Chemotactic FactorsIBA
01/2020 - 01/2002
7Peptides (Polypeptides)IBA
01/2020 - 01/2002
6Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2004
6LigandsIBA
06/2014 - 11/2002
5Glucose (Dextrose)FDA LinkGeneric
01/2019 - 12/2010
5G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2010 - 11/2002
5Amyloid beta-PeptidesIBA
02/2005 - 01/2002
4ChemokinesIBA
01/2014 - 11/2003
4Amyloid (Amyloid Fibrils)IBA
04/2013 - 12/2009
3GTP-Binding Proteins (G-Protein)IBA
10/2020 - 10/2004
3Chemokine ReceptorsIBA
06/2013 - 01/2003
3Biological ProductsIBA
04/2013 - 06/2005
3Islet Amyloid PolypeptideIBA
05/2011 - 01/2010
3Small Interfering RNA (siRNA)IBA
04/2007 - 10/2004
2CathelicidinsIBA
01/2020 - 06/2014
2LipidsIBA
01/2019 - 12/2010
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
08/2009 - 11/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2008 - 01/2007
125-hydroxyvitamin DIBA
11/2021
1hydroxide ionIBA
11/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2021
1Indicators and Reagents (Reagents)IBA
10/2020
1QuercetinIBA
10/2020
1Antimicrobial PeptidesIBA
01/2020
1Estrogens (Estrogen)FDA Link
10/2019
1dorsomorphinIBA
05/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2019
1Proteasome InhibitorsIBA
05/2019
1MicroRNAs (MicroRNA)IBA
11/2016
1Interleukin-8 (Interleukin 8)IBA
02/2016
1CalciumIBA
02/2016
1CCR2 ReceptorsIBA
06/2013
1Dextran SulfateIBA
04/2013
1Insulin (Novolin)FDA Link
04/2013
1Neutralizing AntibodiesIBA
04/2013
1Presenilin-1IBA
04/2013
1Blood Glucose (Blood Sugar)IBA
04/2013
1AzoxymethaneIBA
04/2013
1ResveratrolIBA
04/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2011
1AdipokinesIBA
09/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2011
1Toll-Like Receptor 4IBA
12/2010
1Fatty Acids (Saturated Fatty Acids)IBA
12/2010
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
12/2010
1Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2010
1ovalbumin-alumIBA
04/2010
1EpitopesIBA
02/2010
1sesaminIBA
02/2010
1thioflavin TIBA
12/2009
1PolyphenolsIBA
08/2009
1TeaIBA
08/2009
1Catechin (Z 7300)IBA
08/2009

Therapy/Procedure

2Transplantation
10/2021 - 01/2019
2Therapeutics
01/2021 - 02/2016
1Diet Therapy (Therapy, Diet)
11/2021
1Operative Surgical Procedures
10/2021
1Artificial Skin
10/2021
1Immunotherapy
01/2021
1Precision Medicine
01/2021